Cell-Penetrating Peptide Constructs for pH-Triggered Endosomal Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing cell penetrating peptides (CPPs) face limitations in efficiently delivering cargo, such as siRNA, across lipid membranes due to heterogeneity, low stability, and premature dissociation, often resulting in endosomal trapping and limited intracellular delivery.

Innovation Solution

A membrane-permeable construct comprising a cell penetrating amino acid sequence with modifications, including histidine residues and a fatty acid chain, exhibits pH sensitivity for efficient endosomal release and targeted delivery, particularly effective in low pH cancer microenvironments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If non-covalent cell penetrating amino acid sequence/cargo complexation is used, then simple complex formation with high mixing versatility is achieved, but heterogeneity and low stability of complexes occur, and premature or limited dissociation of cargo from complexes happens

Engineering Contradiction:
Improvecomplex formation simplicityVSAvoidcomplex stability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent modifies the cell penetrating peptide parameters by incorporating specific amino acid sequences with defined properties (e.g., arginine-rich sequences, specific hydrophobic residues) to optimize the balance between complex formation ease and stability. The peptide length, charge density, and hydrophobicity are tuned to achieve stable complexes that resist premature dissociation while maintaining simple formation protocols.

Inventive Principle:
Principle #35Parameter changes

2Strength

If cell penetrating amino acid sequences with both hydrophilic and hydrophobic regions are designed, then cell membrane interaction is enhanced, but endosomal trapping and limited intracellular delivery occur

Engineering Contradiction:
Improvemembrane interaction strengthVSAvoidintracellular delivery efficiency
Core Design Contradiction:
StrengthVSProductivity

Solution Approach 1:

The patent exploits pH-induced phase transitions of the cell penetrating peptide. At endosomal pH (acidic conditions), the peptide undergoes conformational changes or protonation that triggers endosomal escape, releasing the cargo into the cytoplasm. This phase transition mechanism allows strong membrane interaction at neutral pH while enabling efficient intracellular delivery through pH-responsive release in acidic endosomes.

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The peptide structure is designed to be dynamic rather than static, allowing conformational adjustments in response to environmental pH changes. This dynamic behavior enables the peptide to adapt its membrane interaction strength and cargo release properties based on the local pH environment, overcoming endosomal trapping.

Inventive Principle:
Principle #15Dynamics

3Productivity

If existing cell penetrating peptides are used for cargo delivery, then cargo transport across lipid membrane is achieved, but heterogeneity, low stability, and premature dissociation limit effective delivery

Engineering Contradiction:
Improvecargo delivery capabilityVSAvoiddelivery stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent creates composite structures by combining cell penetrating peptide sequences with specific cargo molecules (e.g., siRNA, oligonucleotides) to form stable conjugates or complexes. The composite design integrates the cargo-binding properties of the peptide with the functional properties of the cargo, achieving both stable complexation and efficient intracellular delivery while reducing heterogeneity through defined stoichiometry and structure.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The construct achieves enhanced siRNA delivery with improved stability and reduced toxicity, offering potential for targeted cancer therapy and effective gene silencing.

Implementation Method 1

They form a non-covalent complex mainly via electrostatic interactions

Methodology Applied
Scientific EffectElectrostatic interactions: Electrostatics

Implementation Method 2

although hydrophobic interactions may play a role in the stability of the formed complexes

Methodology Applied
Scientific EffectHydrophobic interactions: Hydrophobe

Implementation Method 3

the constructs of the present invention have good pH sensitivity and are good at delivery of cargo into the intracellular compartment. In particular, the constructs are sensitive to changes in pH which allows for efficient cell delivery of cargo via endosomes

Methodology Applied
Scientific EffectpH sensitivity: Phase Change

Data Source

PatentUS12385042B2Cell-penetrating peptides
Publication Date: 2025.08.12 VECTIOPEP OÜ
  • US12385042B2 patent drawing
  • US12385042B2 patent drawing
  • US12385042B2 patent drawing

AI summary

The present invention provides for a membrane-permeable construct for transport of cargo across a lipid membrane and subsequent delivery of cargo into cells, wherein the construct comprises a cell penetrating amino acid sequence and a fatty acid chain attached to the N terminus thereof, wherein the cell penetrating amino acid sequence comprises the sequence of SEQ ID NO: 1, or comprises a modified sequence of SEQ ID NO: 1, wherein the cell penetrating amino acid sequence comprises two or more histidine residues by substitution to its N-terminal part and/or addition to its N-terminus, and wherein the cell penetrating amino acid sequence is optionally chemically modified at the C terminus.